4.6 Article

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre phase 2 clinical trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。